{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Santa Ana",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "84622",
      "recalling_firm": "McGuff Compounding Pharmacy Services, Inc.",
      "address_1": "2921 W Macarthur Blvd Ste 142",
      "address_2": "N/A",
      "postal_code": "92704-7944",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.",
      "recall_number": "D-0821-2020",
      "product_description": "Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704",
      "product_quantity": "N/A",
      "reason_for_recall": "Presence of Particulate Matter: Particulates observed in vials release for dispensing.",
      "recall_initiation_date": "20190214",
      "center_classification_date": "20200129",
      "termination_date": "20231120",
      "report_date": "20200205",
      "code_info": "Lot #18J1081, Exp 03/10/19"
    }
  ]
}